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Background: Cytotoxic T cells employ perforin and granzyme B to kill tumor cells.
Results: Bim-deficient 3T9-transformed MEF cells are resistant to gzmB-induced apoptosis.
Conclusion: The mitochondrial apoptotic pathway activated via Bim is critically involved in apoptosis induced by mouse
granzyme B.
Significance: Learning how granzyme B induces apoptosis in different tumor cell types will help to predict and increase the
efficacy of cancer immunotherapy.
Cytotoxic T cells (Tc) use perforin and granzyme B (gzmB) to
kill virus-infected cells and cancer cells. Recent evidence sug-
gests that human gzmB primarily induces apoptosis via the
intrinsic mitochondrial pathway by either cleaving Bid or acti-
vating Bim leading to the activation of Bak/Bax and subsequent
generation of active caspase-3. In contrast, mouse gzmB is
thought to predominantly induce apoptosis by directly process-
ing pro-caspase-3. However, in certain mouse cell types gzmB-
mediated apoptosis mainly occurs via the mitochondrial path-
way. To investigate whether Bim is involved under the latter
conditions, we have now employed ex vivo virus-immune mouse
Tc that selectively kill by using perforin and gzmB (gzmBTc) as
effector cells and wild type as well as Bim- or Bak/Bax-deficient
spontaneously (3T9) or virus-(SV40) transformed mouse
embryonic fibroblast cells as targets. We show that gzmBTc-
mediated apoptosis (phosphatidylserine translocation, mito-
chondrial depolarization, cytochrome c release, and caspase-3
activation) was severely reduced in 3T9 cells lacking either Bim
or both Bak and Bax. This outcome was related to the ability of
Tc cells to induce the degradation of Mcl-1 and Bcl-XL, the anti-
apoptotic counterparts of Bim. In contrast, gzmBTc-mediated
apoptosis was not affected in SV40-transformed mouse embry-
onic fibroblast cells lacking Bak/Bax. The data provide evidence
that Bim participates in mouse gzmBTc-mediated apoptosis of
certain targets by activating the mitochondrial pathway and
suggest that the mode of cell death depends on the target cell.
Our results suggest that the various molecular events leading to
transformation and/or immortalization of cells have an impact
on their relative resistance to the multiple gzmBTc-induced
death pathways.
Cytotoxic T cells (Tc)4 and natural killer cells control viral
infections and cellular transformation, in part through the
granule secretory pathway where the pore-forming protein per-
forin (perf) delivers a family of serine proteases, the granzymes,
into the cytosol of the target cell (1–3). Tc cells are recognized
as novel tools to eliminate cancer cells that do not respond to
conventional treatments.
Among granzymes, gzmB is the most potent pro-apoptotic
mediator in a variety of in vitro propagated target cells (3– 6).
The apoptotic potential of other granzymes such as gzmA and
gzmK remains controversial (3, 7, 8).
In light of the multicomponent system of granule exocytosis,
mechanistic insights have mainly been obtained in studies with
isolated proteins, i.e. perf and/or granzymes, in vitro. For gzmB,
hundreds of possible substrates have been considered, but in
most instances their biological relevance is unclear (5, 9). Two
major apoptotic pathways have been proposed for gzmB, both
terminally activating effector caspase-3. gzmB may directly
process procaspase-3 (10, 11). Alternatively, gzmB engages the
mitochondrial death pathway by converting Bid to tBid (11–
16). In turn, tBid oligomerizes Bak and Bax, which permeabilize
mitochondria. Factors are released that enhance (e.g. cyto-
chrome c) and de-repress (e.g. SMAC/Diablo) mitochondrial
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apoptosome formation (17, 18), controlling caspase-3
activation.
Nevertheless, the factors that initiate and perpetuate the
engagement of these pathways in vivo have not been fully clar-
ified (9). In this regard, biochemical studies suggest that the
pathway(s) engaged may depend on the species of gzmB as well
as the source and quality of target cells (19 –21). Thus, mouse
gzmB seems to mainly process pro-caspase-3 to its active form
directly, whereas human gzmB preferentially induces active
caspase-3 indirectly by cleaving Bid, which modulates subse-
quent mitochondrial processes. Adding another dimension,
isolated human gzmB has been shown to cleave the anti-apo-
ptotic protein, Mcl-1, thereby releasing the pro-apoptotic
BH3-only protein Bim (22). Bim down-regulation by siRNA
completely blocks human gzmB-induced apoptosis. Bim is a
BH3-only member of the Bcl-2 family, which has been shown to
activate Bak and/or Bax directly, independent of other BH3-
only proteins like Bid (23–25). The combined studies suggest
that caspase-3 and Bid are not the only intracellular targets of
gzmB (26).
To closely simulate events in vivo, we have delineated apo-
ptotic pathways with mouse ex vivo virus-immune Tc cells that
selectively kill by a perf/gzmB-dependent mechanism (11, 27).
Here, we analyze the role of Bim in gzmB-mediated apoptosis,
using spontaneously (3T9) or virus (SV40)-transformed MEF
cells and their Bim- or Bak/Bax-deficient variants. We have
unexpectedly learned that, in contrast to SV40 MEF cells, apo-
ptosis triggered in 3T9 MEF cells depends upon activation of
the mitochondrial death pathway mediated by Bim. These
results indicate that the preferred cell death pathway activated
by gzmB is not only influenced by the species of the protease but
also depends upon the transformation state of the target cell
subject to Tc cell attack.
EXPERIMENTAL PROCEDURES
Mouse Strains
Inbred B6 and mouse strains deficient for gzmA (gzmA/),
gzmAxB (gzmAxB/), and perfxgzmAxgzmB (PAB/), bred
on the B6 background, were maintained at the Agrifood
Research and Technology Centre of Aragón, and genotypes
were analyzed as described (27). Mice (8 –10 weeks old) were
studied and were used in accordance with the Federation of
Laboratory Animal Science Association guidelines under the
supervision and approval of Comite Etico para la Experimenta-
cion Animal (Ethics Committee for Animal Experimentation)
from Agrifood Research and Technology Centre of Aragón
(number 2011-01).
Cells
Mouse embryonic fibroblasts were cultured in DMEM with
10% FBS at 37 °C, 5% CO2. BakxBax/ SV40-transformed
MEFs were generously provided by Dr. Christoph Borner
(Institute of Molecular Medicine and Cell Research, Center for
Biochemistry and Molecular Research, Freiburg, Germany)
(28) and compared with a MEF WT cell line generated by the
same group. Bim/ 3T9-transformed MEFs and Bim/
SV40-transformed MEFs were generously provided by Dr.
Andeas Strasser (Walter and Eliza Hall Institute of Medical
Research, Melbourne, Australia) and Gabriel Gil (Institut
Municipal d’Investigació Mèdica, Barcelona, Spain), respec-
tively, and compared with a MEF WT cell line generated by the
same group.
BakxBax/ 3T9-transformed MEFs were generously pro-
vided by Dr. Christoph Borner. Caspase-3x7/ MEF cells were
generously provided by Dr. Richard Flavell. In some cases, the
caspase-3 inhibitor Ac-DEVD-fmk (Bachem; 100 M) was
added to cell cultures as described (27).
Generation of Ex Vivo Virus-specific CD8 T Cells
Mice were infected with 105 pfu of LCMV strain WE intra-
peritoneally according to established protocols (29). On day 8
postinfection, CD8 cells were positively selected from spleen
using -CD8-MicroBeads (Miltenyi Biotec, Germany) with a
MACS (Miltenyi Biotec) and resuspended in RPMI 1640
medium and 5% heat-inactivated FBS before use in cytotoxic
assays. Purity of selected CD8 cells was assessed by FACS
staining and found to be between 95 and 98% in all cases.
Ex Vivo Cytotoxicity Assay
Target cells were preincubated with the LCMV-immu-
nodominant peptide gp33 (Neosystem Laboratoire) for 1–2 h,
and ex vivo CD8 cells were stained with CellTracker Green
(Invitrogen). Effector and target cells were incubated at a ratio
of 10:1 (effector/target) at 37 °C. Subsequently, different apo-
ptotic parameters were tested in the CellTracker Green nega-
tive target population by FACS with a FACSCalibur (Pharmin-
gen) and CellQuest software.
To perform intracellular stainings, CD8 cells were not
pre-stained with CellTracker Green. Instead, after incuba-
tion with target cells, they were labeled with -CD8-APC
mAb (Pharmingen), fixed with 4% paraformaldehyde (PFA) in
PBS, and used for the different stainings. In this case, the differ-
ent parameters were tested in the CD8-negative target popula-
tion as indicated.
For real time cytotoxic assays, a time-lapse imaging system
was performed with a Leica AF6000 LX microscope within a
temperature- and CO2-controlled chamber. Effector and target
cells were incubated at a ratio of 10:1 (effector/target) in the
presence of annexin V-FITC and propidium iodide (10 g/ml)
for 3 h with images acquired every 2 min.
Analysis of Pro-apoptotic Processes by Flow Cytometry
Cell Death Induced by ex Vivo Tc Cells in MEF Cells—For cell
membrane and mitochondrial membrane perturbations, phos-
phatidylserine (PS) exposure on plasma membrane and cell
membrane integrity were measured by three-color flow cytom-
etry using annexin-V and 7-AAD as described earlier (27).
Changes in mitochondrial membrane potential (m) was
measured by three-color flow cytometry using the fluorescent
probe tetramethylrhodamine ethyl ester (25 nM; Molecular
Probes).
Caspase-3 Activation—Caspase-3 activation was analyzed by
FACS as described (27). Cells were fixed with 4% PFA and incu-
bated with a FITC-labeled mAb against the active form of
caspase-3 (clone C92605; Pharmingen) diluted in 0.1% saponin
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in PBS. After two washes, cells were resuspended in 1% PFA and
analyzed by flow cytometry.
Cytochrome c Release—Cytochrome c release was analyzed
by flow cytometry as described earlier (30). Briefly, cells were
mildly permeabilized with 25 g/ml digitonin plus 100 mM KCl
on ice for 5 min, washed with cold PBS, fixed in 4% PFA, per-
meabilized with 0.1% saponin, and incubated with the -cyto-
chrome c mAb 6H2.B4 (BD Biosciences) or with mouse IgG
isotype followed by -mouse-Alexa 488 secondary antibody
(Invitrogen). Cells were resuspended in 1% PFA and analyzed
by flow cytometry.
Analysis of Mcl-1 and Bcl-XL Degradation—Cells were per-
meabilized with 0.1% saponin and 5% FBS in PBS and then
incubated with the -Mcl-1 (Abcam) or -Bcl-XL (clone 54H6;
Cell Signaling) mAb or with rabbit IgG isotype control followed
by -rabbit-Alexa 488 secondary antibody (Invitrogen). Cells
were resuspended in 1% PFA, and Mcl-1 degradation was ana-
lyzed by FACS.
Clonogenic Assay
MEF cells were pretreated with the LCMV immunodomi-
nant peptide gp33 for 1 h prior to incubation with ex vivo-
derived LCMV-immune Tc cell at 10:1 effector/target cell ratio
at 37 °C. After 4 h, cells were trypsinized, and 100 cells were
seeded per well in a final volume of 3 ml in a 6-well plate. Cells
were then allowed to grow during 7 days at 37 °C. After that
time, medium was removed, and cell colonies were counted
after fixing and dying them for 20 min with a mixture of glutar-
aldehyde (6% v/v) and crystal violet (0.5% w/v) at room
temperature.
Western Blot
5  105 cells were washed in PBS and lysed in a buffer con-
taining 1% Triton X-100 during 15 min on ice. Soluble protein
fraction was recovered by centrifugation and separated by SDS-
PAGE. The proteins were then transferred to a PVDF mem-
brane and blocked with 5% fat-free milk. The following primary
antibodies (dilution) were incubated overnight at 4 °C: -Bid
(1:5000) from R&D Systems; -Bim (1:1000) from Calbiochem;
-Bcl-2 (1:500) from Abcam; -Mcl-1 (1:1000) from Santa Cruz
Biotechnology; -Bak (1:1000) from Abcam; -Bax (1:500),
-XIAP (1:250), -cytochrome c (1:1000), and -Smac/DIABLO
(1:1000) from BD Biosciences; and -caspase-3 (1:1000) and
-caspase-9 (1:1000) from Cell Signaling. Subsequently, after a
washing step and depending on the primary antibody used,
blots were incubated during 1 h at room temperature with sec-
ondary -mouse or -rabbit IgG antibodies conjugated with
HRP (Sigma) at a 1:20,000 dilution.
siRNA Transfection
Stealth RNAiTM siRNAs (Life Technologies) were used to
knock down Bim and Bid expression in MEF cells. siRNAs were
transfected with HiPerfect transfection reagent (Qiagen). The
next sequences used were as follows: Bim siRNA, 5-TCCGCT-
TATTTAAATGTCTTA-3; Bid siRNA, 5-AUCAGCAUG-
GCCUUGUCGUUCUCCA-3; and control siRNA, 5-CAC-
CCTCAAATGGTTATCTTA-3.
Drug-induced Cell Death Assay
105 cells were cultured with 40 M sorafenib (Bayer) or 2.0 nM
bortezomib (Millennium Pharmaceuticals) for 18 h in DMEM,
10% heat-inactivated FBS. Subsequently, PS exposition was
measured by FACS as described above.
Determination of HLA-I Surface Expression by Flow Cytometry
2  105 cells were stained for 15 min at 4 °C with anti-H-2Kb-
FITC or isotype control (rabbit IgG-FITC) in 100 l of PBS, 5%
FBS. Both antibodies were obtained from BD Biosciences. Cells
were washed and analyzed by flow cytometry.
Statistical Analysis
The statistical analysis of the difference between means of
independent samples was performed using the unpaired t test.
The results are given as the confidence interval (p) and are
considered significant when they are 0.05.
RESULTS AND DISCUSSION
Bim-deficient 3T9 MEF Cells Resist Cell Death Induced by
gzmBTc Cells—We have established an in situ mouse model
to characterize apoptotic processes induced by perf and gzmB
using ex vivo LCMV-specific Tc cells obtained from mice defi-
cient in gzmA (gzmBTc). gzmBTc cells kill a variety of tar-
gets, including EL4, MC57G, and virus-transformed MEF cells
(SV40) in short term assays via perf and gzmB (11, 27, 29). Using
this model, we examined the role of Bim during the activation of
the mitochondrial cell death pathway in spontaneously (3T9)
and virally transformed (SV40) MEF cells. As described previ-
ously for SV40 MEF cells (11), gzmBTc cells also kill 3T9 MEF
cells through a perf and gzmB pathway, without engaging the
extrinsic cell death pathway mediated by FasL or tumor necro-
sis factor-related apoptosis-inducing ligand (TRAIL) (Fig. 1).
Indeed, SV40 and 3T9 MEF cells are resistant to both recombi-
nant TRAIL as well as to the cytotoxic anti-Fas antibody Jo-2
(data not shown). The apoptotic phenotype was confirmed by
time-lapse fluorescence microscopy (see Fig. 1C). WT 3T9
MEF cells labeled with gp33 peptide and incubated with
gzmBTc showed extensive membrane blebbing and PS trans-
location (annexin V reactivity) prior to plasma membrane dam-
age (propidium iodide uptake) and nuclear condensation. How-
ever, these changes were not observed in control 3T9 MEF cells
or in 3T9 MEF cells incubated with gzmBTc in the absence of
gp33 peptide.
Human gzmB has been shown to induce cell death in Jurkat
cells by degradation of Mcl-1 and subsequent release of pro-
apoptotic Bim (22, 26, 31). We therefore asked whether Bim
also contributes to gzmB-mediated apoptosis in mice by incu-
bating ex vivo mouse gzmB Tc cells with either WT or Bim-
deficient 3T9 MEF cells (3T9 MEF.Bim/). Compared with
WT cells, PS translocation as well as membrane permeabiliza-
tion (7-AAD) were completely abolished, and mitochondrial
depolarization was significantly reduced in 3T9 MEF.Bim/
(Fig. 2, A and B). The results therefore indicate a major role for
Bim in the execution of 3T9 cells by ex vivo gzmB secreting
Tc cells, the most physiological model currently available for
the study of cytotoxic cell granule-mediated apoptosis. As
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expected (32), similar results were obtained with 3T9 MEF
cells deficient in the downstream effectors, Bak and Bax (3T9
MEF.BakxBax/).
Notably, the fact that Bim-deficient 3T9 MEF cells were
similarly sensitive to the cytotoxic effect of the protein
kinase inhibitor, sorafenib, or the proteasome inhibitor,
bortezomib (Fig. 2C), indicates that their resistance to
gzmB Tc cell-mediated apoptosis is not due to a general-
ized refractory state of the transformed cell line. Supporting
this hypothesis, we show that Bim down-regulation by
siRNA in WT 3T9 MEF cells inhibits PS translocation as well
as membrane permeabilization induced by (gzmBTc cells
(Fig. 2D)). In the presence of the caspase-3 inhibitor, Ac-
DEVD-fmk, PS translocation, membrane permeabilization
(Fig. 2A), and mitochondrial depolarization mediated by
gzmB Tc cell (Fig. 2C) were reduced in WT 3T9 MEF cells,
confirming that induction of these three parameters requires
active caspase-3 (11, 27, 33).
FIGURE 1. Cell death induced by ex vivo-derived LCMV-specific Tc cells from gzmA/, gzmAxB/, and perfxgzmAxB/ (PAB/) mouse strains. 3T9
MEF WT (A) and SV40 MEFWT (B) cells were incubated with ex vivo virus immune CD8 cells from either gzmA/, gzmAxB/, and PAB/ mice in the presence
(gp) or absence (gp) of the LCMV peptide gp33 for 3 h. Subsequently, PS exposure on plasma membrane (annexin-V-FITC) and 7-AAD uptake were analyzed
by three-color flow cytometry in the cell population negative for CD8 expression as described under “Experimental Procedures.” A representative experiment
is shown in the left panels. Numbers correspond to the percentage of cells in each quadrant. Data in the right panel are represented as the mean 	 S.D. of three
independent experiments. *, p  0,05; **, p  0,01; ***, p  0,001. No symbol means not significant. C, 3T9 MEF WT cells were incubated with ex vivo virus
immune CD8 cells from gzmA/mice in the presence of the LCMV peptide gp33, annexin V-FITC, and PI for 3 h. Sequential images were taken every 2.5 min
as indicated under “Experimental Procedures.” DIC, differential interference contrast.
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FIGURE 2. gzmB Tc cells induce cell death in 3T9 MEF.WT but neither in 3T9 MEF.Bim/ nor in 3T9 MEF.BakxBax/. MEF.WT, MEF.Bim/, and
MEF.BakxBax/ cells were incubated with ex vivo virus-immune CD8 cells from gzmA/ mice, in the presence (gp) or absence (gp) of the LCMV peptide
gp33 for 3 h. Subsequently, PS exposure on plasma membrane (annexin-V-FITC) and 7-AAD uptake (A) and, in parallel, m loss (TMRE, B) were analyzed by
three-color flow cytometry in the cell population negative for CD8 expression as described under “Experimental Procedures.” In some cases MEF cells were also
preincubated with the caspase inhibitor Ac-DEVD-fmk 100 M. A, representative experiment is shown in the left panels. Numbers correspond to the percentage
of cells in each quadrant. Data in the right panel are represented as the mean 	 S.D. of three independent experiments. B, histograms show a representative
experiment of three independent experiments. Numbers correspond to the percentage of cells in regions marked by the horizontal bar. Data in the left panel are
represented as the mean 	 S.D. of three independent experiments. C, MEF.WT, MEF.Bim/, and MEF.BakxBax/ cells were incubated with sorafenib (Sorf, 40
mM) and bortezomib (Bort, 20 mM) for 18 h. Subsequently, PS exposure on plasma membrane (annexin-V-FITC) was analyzed. Data in this panel are represented
as the mean 	 S.D. of two independent experiments. *, p  0,05; **, p  0,01; ***, p  0,001. No symbol means not significant. D, MEF.WT, MEF.Bim/, or
MEF.WT cells treated with siRNA against Bim (siBim) were incubated with ex vivo virus immune CD8 cells from gzmA/ mice, in the presence (gp) or
absence (gp) of the LCMV peptide gp33 for 3 h. Subsequently, PS exposure on plasma membrane (annexin-V-FITC) and 7-AAD uptake were analyzed. Bim
expression in WT, Bim/, and siBim-treated cells was analyzed by immunoblot (BimEL isoform). Actin served as loading control.
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Caspase-3 Activation Induced by gzmB Tc Cells Depends on
Bim Expression—The demonstration that gzmB Tc cell-in-
duced PS translocation and mitochondrial depolarization are
suppressed by Ac-DEVD-fmk in WT 3T9 MEF prompted us
to analyze the sequence of pro-apoptotic events elicited by
gzmB in 3T9 MEF cells. Accordingly, we analyzed caspase-3
activation in 3T9 MEF.Bim/ cells exposed to gzmB Tc
cells. The level of active caspase-3 was markedly but not
completely reduced in the 3T9 MEF.Bim/ cells (Fig. 3A),
suggesting that activation of caspase-3 largely depends on
expression of Bim and subsequent induction of mitochon-
drial processes. This hypothesis was further supported by
the data that caspase-3 activation was similarly reduced in
3T9 MEF.BakxBax/ cells upon incubation with gzmB Tc
cells (Fig. 3A).
Activation of caspase-3 via the mitochondrial pathway has
been shown to depend on the release of cytochrome c from
Bak/Bax-permeabilized mitochondria and its formation,
together with dATP, Apaf-1, and caspase-9, of the apoptosome
(34). To confirm that the reduction of caspase-3 activation
observed in 3T9 MEF.Bim/ and BakxBax/ cells correlated
with reduced cytochrome c release, this release was measured
in target cells incubated with gzmB Tc cells (11). Slightly mod-
ified from the technique reported by Waterhouse and Trapani
(30), this assay determines the level of intramitochondrial cyto-
chrome c in target cells exposed to Tc cells. gzmB Tc cells
readily induced cytochrome c release from the mitochondria of
3T9 MEF.WT cells but not in MEF cells, which lacked either
Bim or both Bak and Bax (Fig. 3B). Furthermore, cytochrome c
release was completely inhibited by DEVD-fmk suggesting that
mitochondrial outer membrane permeabilization (MOMP)
requires caspase-3 activation upstream of the mitochondria.
Although 3T9 MEF cells express high levels of Bid (Fig. 5), it
seems that, in contrast to other cell types, Bid is not able to
FIGURE 3. Caspase-3 activation and cytochrome c release induced by gzmB Tc cell in 3T9 MEF. MEF.WT, MEF.Bim/, and MEF.BakxBax/ cells or
MEF.WT cells treated with a siRNA against Bim (siBim) or Bid (siBid) were incubated with ex vivo virus-immune CD8 cells from gzmA/ mice, in the presence
(gp) or absence (gp) of the LCMV peptide gp33 for 3 h (A) or 2 h (B). A, caspase-3 activation was analyzed by flow cytometry in the target cell population with
a mAb against the active form of caspase-3. Histograms show a representative experiment of three independent experiments. Numbers correspond to the
percentage of cells with activated caspase-3, limited by regions marked by the horizontal bar. Data in the right panel are represented as the mean 	 S.D. of three
independent experiments. B, cytochrome c release from mitochondria was analyzed by flow cytometry in the cell population negative for CD8 expression as
described under “Experimental Procedures.” Histograms show a representative experiment of two independent experiments. Data in the right panel are
represented as the mean 	 S.D. of two independent experiments. *, p  0.05; **, p  0.01. No symbol means not significant. C, MEF.WT cells were treated with
a siRNA against Bim (siBim) or Bid (siBid) and incubated with ex vivo virus immune CD8 cells from gzmA/ mice, in the presence (gp) or absence (gp) of
the LCMV peptide gp33 for 2 h. Cytochrome c release from mitochondria was analyzed by flow cytometry in the cell population negative for CD8 expression
as described under “Experimental Procedures.”
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initiate cytochrome c release in 3T9 MEF cells. This hypothesis
is confirmed in Fig. 3C where siRNA against Bid only partially
reduces cytochrome c release, meanwhile siRNA against Bim
completely blocked release.
These results suggest that gzmB directly activates caspase-3
(Fig. 3A) to initiate MOMP and the release of cytochrome c.
Because this process also depends on Bim and Bak and Bax (Fig.
3B), altogether our data suggest that activation of the mito-
chondrial pathway mediated by Bim occurs through caspase-3
when intact Tc cells are examined.
gzmB Tc Cells Initiate Degradation of the Anti-apoptotic
Protein, Mcl-1, in 3T9 MEF Cells—Isolated human gzmB has
been shown to directly cleave Mcl-1 in human target cells
blocking its ability to inhibit the pro-apoptotic activity of Bim
(22, 26). However, our data (Fig. 3) suggest that this process
could be mediated by caspase-3 in the mouse system. We there-
fore determined whether Mcl-1 is similarly degraded in mouse
target cells incubated with mouse gzmB Tc cells and whether
caspases-3 and -7 are participants in this process. Because
Mcl-1 is also highly expressed in ex vivo Tc cells, the detection
of processed target cell-associated Mcl-1 by immunoblot is
problematic. To avoid this technical pitfall, a protocol was
established to measure Mcl-1 degradation by flow cytometry. A
mAb against a peptide that contained the site cleaved by human
gzmB and caspase-3 (Asp-127) was used to monitor the level of
intact Mcl-1. Conserved in both human and mouse (26), cleav-
age of this site is predicted to reduce the binding of the detect-
ing mAb. A similar approach has been successfully employed to
analyze the cleavage of other gzm substrates by Tc cells (27).
Upon incubation with gzmB Tc cells, the expression of
Mcl-1 in nonpulsed 3T9 MEF cells (gp) is rather homoge-
neous (Fig. 4A). In contrast, Mcl-1 expression was lost in most
gp33-pulsed 3T9 MEF cells (70%) under similar conditions.
Loss of Mcl-1 preceded signs of cell death indicating that its
degradation designated an early proteolytic event during
gzmB-induced cell death and was not due to protein loss in
dying cells. Ac-DEVD-fmk treatment of 3T9 MEF.WT cells
significantly reduced the proteolysis of Mcl-1 degradation
suggesting that caspase-3 is mainly responsible. Indeed, a
similar result was observed in SV40 MEF Casp3x7/ MEF
cells (Fig. 4B).
Other anti-apoptotic proteins like Bcl-XL have also been
shown to bind Bim preventing its pro-apoptotic activity. Using
an approach similar to Mcl-1, we found that gzmBTc also
degraded Bcl-XL (Fig. 4C) among WT 3T9 MEF cells in a caspase-
dependent manner, suggesting that Bim activation could be medi-
ated by degradation of both Bcl-XL and Mcl-1. Bcl-2 degradation
was not analyzed by FACS because its expression in MEF cells is
almost undetectable (data not shown).
FIGURE 4. Mcl-1 and Bcl-XL degradation, transcriptional regulation of Bim and survival assay. A–C, 3T9 or SV40 MEF.WT and MEF.Casp3x7
/ (B) cells were
incubated with ex vivo virus-immune CD8 cells from gzmA/ mice, in the presence (gp) or absence (gp) of the LCMV peptide gp33 for 3 h. Mcl-1 and
Bcl-XL degradation was analyzed by flow cytometry in the target cell population with a mAb against a specific Mcl-1 epitope. Histograms show a representative
experiment of three independent experiments. Numbers correspond to the percentage of cells with Mcl-1 degraded, limited by regions marked by the
horizontal bar. In the second histogram (A and C), the filled histograms represent cells without gp33 (gp), black line represents cells plus gp33 (gp33). and
broken line represents cells with gp33 plus DEVD (gp-DEVD). B, black and blue histograms correspond to the isotype antibody control and Mcl-1 specific mAb,
respectively. Numbers in gray corresponds to the % of annexin V cells. Data in the right panel are represented as the mean 	 S.D. of three independent
experiments. D and E, gp33-pulsed 3T9 MEF.WT and SV40 MEF.WT cells were incubated with ex vivo virus-immune CD8 cells from gzmA/ mice in the
presence of salubrinal, 10 M (D), or cycloheximide (chx) (E) for 2 h. Subsequently, PS exposure on plasma membrane (annexin-V-FITC) was analyzed. Data in this
panel are represented as the mean 	 S.D. of two independent experiments. *, p  0,05; **, p  0,01; ns, not significant. F, for survival assay, MEF.WT,
MEF.Bim/, and MEF.BakxBax/ cells were incubated with ex vivo virus-immune CD8 cells from gzmA/ mice, in the presence (gp) or absence (gp) of
the LCMV peptide gp33. 3 h after incubation, cells were washed, trypsinized, and counted. 100 cells per well were seeded in 6-well plates and incubated in fresh
medium for 7 days. After incubation, cells were stained with crystal violet, and colonies were counted. Survival was calculated as percentage of colonies relative
to the colonies in the controls. Values were represented as the mean 	 S.D. of four independent experiments. *, p  0,05; **, p  0,01; ***, p  0,001. No symbol
means not significant.
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The endoplasmic reticulum stress inhibitor, salubrinal (35),
which transcriptionally regulates Bim, did not alter gzmB Tc-
induced apoptosis in 3T9 cells (Fig. 4D). Bim expression is
therefore not likely to be regulated by endoplasmic reticulum
stress pathways (36), a notion consistent with the observation
that gzmB Tc-mediated cell death is an extremely rapid phe-
nomenon (37). Because the inhibitor of protein synthesis,
cycloheximide, was inactive (Fig. 4E), other pathways of tran-
scriptional regulation of Bim were not examined. As control,
cycloheximide sensitized MEF cells to apoptosis induced by the
cytotoxic anti-Fas antibody JO2.
To efficiently induce cell death, the participation of Bim and
the subsequent induction of the mitochondrial pathway appear
essential. However, the exact mechanism by which gzmBTc
initiates this process is not completely clear. Our findings sug-
gest that gzmB cleaves a small amount of caspase-3 which, in
turn, cleaves Mcl-1 and inhibits its ability to block pro-apopto-
tic Bim. Subsequently, Bim would activate the mitochondrial
apoptotic pathway heightening caspase-3 activation. This
amplification loop therefore seems necessary to maximize PS
translocation and other signs of apoptosis. Notably, a small
quantity of Mcl-1 is cleaved in the absence of caspase-3 and
caspase-7 (Fig. 3), but this amount is not sufficient to induce
MOMP and activation of the mitochondrial cell death pathway
because inhibition of caspases entirely blocks cytochrome c
release (Fig. 3B). This mechanism is supported by previous
findings showing that cleavage by caspases or granzyme B after
Asp-127 and Asp-157 residues generate Mcl-1 fragments that
bind Bim (26, 38). However, for unclear reasons, these frag-
ments do not interfere with the pro-apoptotic activity of Bim.
Cleavage of Mcl-1 may not be sufficient to activate pro-apo-
ptotic Bim because other anti-apoptotic proteins, especially
Bcl-XL, have been shown to block Bim (39, 40). We also show
that Bcl-XL is degraded during cell death induced by gzmBTc
(Fig. 4C), thus both Mcl-1 and Bcl-XL degradation may be nec-
essary for optimal participation of Bim during apoptosis
induced by gzmB-associated Tc cells.
Absence of Bim Does Not Protect Cells from gzmBTc in a
Clonogenic Survival Assay—To determine whether target cells
lacking Bim or Bak/Bax unequivocally resist gzmB Tc cells, we
examined the susceptibility with the clonogenic assay. MEF
cells deficient in either Bim or Bak and Bax similarly do not have
a survival advantage that exceeded WT cells (Fig. 4F). There-
fore, loss of Bim does not confer an absolute resistance to perf
FIGURE 5. Implication of mitochondrial apoptotic pathway in cell death induced by gzmB Tc in MEF 3T9 and MEF SV40. 3T9 MEF.WT, 3T9 MEF.BakxBax/,
SV40 MEF.WT, and SV40 MEF.BakxBax/ cells were incubated with ex vivo virus-immune CD8 cells from gzmA/ mice in the presence (gp) or absence
(gp) of the LCMV peptide gp33 for 3 h. Subsequently, PS exposure on plasma membrane (annexin-V-FITC) and 7-AAD uptake (A) and, in parallel, m loss
(TMRE) and caspase-3 activation (B) were analyzed by three-color flow cytometry in the cell population negative for CD8 expression. A, representative
experiment is shown in the left panels. Numbers correspond to the percentage of cells in each quadrant. Data in the right panel are represented as the mean 	
S.D. of six independent experiments. B, histograms show a representative experiment of three independent experiments. Numbers correspond to the percent-
age of cells in regions marked by the horizontal bar. C, SV40 MEF.WT and SV40 MEF.Bim/ cells were incubated with ex vivo virus-immune CD8 cells from
gzmA/ mice, in the presence (gp) or absence (gp) of the LCMV peptide gp33 for 3 h. Subsequently, PS exposure on plasma membrane (annexin-V-FITC)
and 7-AAD uptake was analyzed by three-color flow cytometry in the cell population negative for CD8 expression. A representative experiment is shown in the
left panels. Numbers correspond to the percentage of cells in each quadrant. Data in the right panel are represented as the mean 	 S.D. of two independent
experiments. *, p  0,05; **, p  0,01; ***, p  0,001. No symbol means not significant. Data in the right panels are represented as the mean 	 S.D. of three
independent experiments. D, lysates of MEF 3T9 WT, MEF 3T9 Bim/, MEF 3T9 BakxBax/, MEF SV40 WT, and MEF SV40 BakxBax/ cells were prepared and
Bim (BimEL isoform), Bid, Bak, Bax, Bcl-XL, Mcl-1, XIAP, Smac/DIABLO, caspase-3, and caspase-9 expression were analyzed by Western blot as described under
“Experimental Procedures.” Actin was used as loading control.
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and gzmB delivered by intact Tc. These data indicate that Bim,
Bak, and Bax contribute to the induction of apoptotic pro-
cesses, as defined by a number of in vitro markers, but in their
absence other gzmB-mediated pathways are likely operative to
kill MEF cells as defined by the clonogenic assay. These data
support previous findings showing that the simultaneous
blockade of mitochondrial and caspase-3 pathways does not
result in long term survival of target cells upon their exposure to
gzmB Tc (11).
Mitochondrial Apoptotic Pathway Is Involved in gzmBTc
Cell-mediated Apoptosis of 3T9 but Not SV40 MEF Cells—Our
results indicate that gzmBTc cell-induced apoptosis of 3T9
MEF cells is dependent on the participation of Bim, Bak, and
Bax. These results contradict previous data showing that both
isolated mouse gzmB (16) and mouse gzmBTc cells (11)
induce apoptosis and cell death of Bak/Bax-deficient SV40 MEF
targets.
To analyze whether the molecular mechanism of gzmB-me-
diated apoptosis is influenced by the type of cell transformation
in MEF cells (3T9 versus SV40), we compared the potential of
gzmBTc cells to induce cell death in 3T9 or SV40 MEF cells
deficient in Bak and Bax. In contrast to 3T9 MEF.BakxBax/
cells, SV40 MEF.BakxBax/ cells as well as both WT MEF cell
lines were equally susceptible to gzmBTc-induced apoptosis
as determined by PS translocation (Fig. 5A), membrane per-
meabilization (Fig. 5A), mitochondrial depolarization (Fig. 5B),
and caspase-3 activation (Fig. 5B). Therefore, in this model, the
apoptotic processes activated by perf and gzmB are not dictated
only by the origin of target cells, but intriguingly by the type of
transformation of individual cell lines. Confirming this hypoth-
esis we show, in contrast to 3T9 MEF.Bim/ cells (see Fig. 1),
SV40 MEF.Bim/ cells are equally susceptible to gzmBTc as
WT SV40 MEF cells (Fig. 5C).
The 3T9- and SV40-associated mutational events that lead to
cellular immortalization likely differ, thereby influencing the
susceptibility of these targets cells to gzmB Tc cell-facilitated
apoptotic events. We have measured the expression of several
proteins that are involved in gzmB-induced apoptosis, includ-
ing caspase-9 and -3, Bim, Bid, Bak, Bax, Bcl-2, Bcl-XL, Mcl-1,
SMAC/Diablo, and XIAP (Fig. 5D). Bcl-2 was not detected in
MEF cells (data not shown). The finding that all tested proteins
were similarly expressed in both transformed cell lines suggests
that more subtle alterations contribute to the relative suscepti-
bility of 3T9 and SV40 cells to gzmBTc cell-mediated cytoly-
sis. Thus, a more detailed investigation of proteins mutated in
these two cell types is required to further our understanding of the
inter-relationship between immortalization, oncogenic transfor-
mation, and susceptibility to perf-gzmB-mediated apoptosis.
Our results indicate that gzmBTc cells inhibit the clonogenic
expansion of both 3T9 (Fig. 4) and SV40 MEF.BakxBax/ (data
not shown) (11) cells, although the apoptotic markers tested are
only expressed in SV40 transformed cells. A priori, two possible
explanations may account for these findings. The cells are not
killed by gzmB Tc cells but are unable to proliferate. Alterna-
tively, the 3T9 cells are dying without displaying traditional
apoptotic markers.
Based on our findings, it is tempting to speculate that muta-
tions, which overcome cell senescence and lead instead to
immortalization, contribute to the escape of tumor variants
that resist gzmB-induced apoptosis (41). Because of the critical
importance of perf and gzmB during Tc and natural killer cell-
mediated responses, therapeutic endeavors should focus on
profiling apoptotic and anti-apoptotic proteins in malignant
cells from patients to optimize cancer immunotherapy. The
study of a greater number of characterized target cells will be
required to support this hypothesis. However, our data
unequivocally show that Bim participates in the molecular
mechanism of apoptosis induced by perf and gzmB of mouse Tc
cells (summarized in Fig. 6), adding another physiologically val-
idated player to the pleiotropic intracellular mechanism of
gzmB-induced apoptosis.
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